Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Chinese Medical AI Start-up Synyi Raised $15.7 Million Series B

publication date: May 2, 2018

Synyi, an artificial intelligence start-up located in Shanghai Zhangjiang, received $15.7 million Series B led by GGV Capital. Sequoia Capital China and Zhen Fund also participated in the round. Synyi will use the fund to develop medical natural language processing, medical data governance and machine learning. While establishing its team and expanding business, Synyi will also explore deeper in the industry standards. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China